Sector Update| 1 September 2017
Automobiles
Maruti Suzuki
CMP: INR7,813
Stock Info
Bloomberg
Equity Shares (m)
M.Cap. (INR b)/(USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
TP: INR8,819 (+13%)
Buy
MSIL IN
302
Domestic sales grew at a healthy 26.7% YoY to 152k
2,025/31.6
7249 / 3868
MSIL’s Aug-17 wholesales came in line at 163,701 units (est. 162,029 units), up 23.8%
5/22/55
Vol up 23.8% YoY to 163.7k units (in line v/s est. of 162k)
Financials Snapshot (INR b)
Y/E MARCH
2018E 2019E 2020E
Sales
806.0 953.5 1,100.3
EBITDA
119.2 153.4 177.4
Adj. PAT
83.4 111.3 128.4
Adj. EPS (INR)* 281.7 374.5 431.5
EPS Gr. (%)
13.3 32.9
15.2
BV/Sh. (INR)
1,371 1,620 1,912
RoE (%)
20.1 22.8
22.2
RoCE (%)
28.0 30.8
30.1
Payout (%)
37.0 32.6
31.1
Valuations
P/E (x)
27.7 20.9
18.1
P/CE (x)
20.8 16.2
14.2
EV/EBITDA (x) 17.1 12.8
10.6
Div. Yield (%)
1.1
1.3
1.4
*Cons.
YoY. YTD growth was at 17%, with residual monthly run-rate at 154.6k units.
Domestic volumes grew by 26.7% YoY to 152k (better than est. of 150k), led by growth
in compact (+52.4% YoY) and UV (+27.6% YoY) segments.
The compact segment grew 18% YoY, led by Baleno and New Dzire sales.
Mid-size segment increased 3.9% YoY, led by Ciaz, despite an increase in prices due to
higher taxes on hybrid cars post GST. Ciaz clocked sales of 6,457 units.
UVs continued their momentum, with 27.6% YoY growth, primarily aided by
incremental volumes of Vitara Brezza, which continues to enjoy a healthy waiting
period.
Export volumes declined 4.7% YoY to 11,701 units (est. of 12,000 units).
The stock trades at 27.7x/20.9x FY18E/19E consolidated EPS of ~INR281/375. Maintain
Buy.
Snapshot of volumes for Aug-17
YoY
Company Sales
Maruti Suzuki
LCVs
Vans
Mini Segment
Compact
(incl Dzire Tour)
Mid Size - CIAZ
UVs
Total Domestic
Export
Aug-17 Aug-16
163,701
730
13,931
35,428
MoM
(%) chg
FY18
estimate
17.1 1,806,406
6,000
1.9
164,170
11.0
459,683
20.8
733,103
YoY (%)
MoM
FY18
FY17
Jul-17
chg
(%) chg
YTD
YTD
132,211
23.8 165,346
-1.0 723,618 617,770
25
703
3.8 2,478
39
12,831
8.6 15,714
-11.3 65,384 64,137
35,490
-0.2 42,310
-16.3 181,248 163,264
52.4 63,116
3.9
6,377
27.6 25,781
26.7 154,001
-4.7 11,345
17.3 292,442 242,007
1.3
-16.8
-1.3
3.1
28,532
104,348
674,432
49,186
25,066
73,536
568,049
49,721
Residual
Residual
Monthly
Gr. (%) Growth (%)
Run rate
15.2
13.9 154,684
-40.9
503
8.0
12.4 14,112
11.0
11.1 39,776
25.3
-6.5
25.9
16.4
0.3
28.5
62,952
74,012 48,565
6,457
6,214
21,442 16,806
152,000 119,931
11,701 12,280
13.8
60,259
41.9
246,454
18.7 1,681,950
-1.1
124,457
-19.4
4,532
16.3 20,301
14.9 143,931
1.3 10,753
Jinesh Gandhi
(Jinesh@MotilalOswal.com); +91 22 3982 5416
Deep Shah
(Deep.S@MotilalOswal.com); +91 22 6129 1533;
Jigar Shah
(Jigar.Shah@MotilalOswal.com); +91 22 6129 1534
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.